Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
LYL797
i
Other names:
LYL797, LYL-797, LYL 797
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(2)
News
Trials
Company:
Lyell Immunopharma
Drug class:
ROR1-targeted CAR-T immunotherapy
Related drugs:
‹
ONCT-808 (1)
BMS-986403 (0)
JCAR024 (0)
LYL119 (0)
PRGN-3007 (0)
RD14-01 (0)
ONCT-808 (1)
BMS-986403 (0)
JCAR024 (0)
LYL119 (0)
PRGN-3007 (0)
RD14-01 (0)
›
Associations
(2)
News
Trials
VERI cancer hierarchy
Reset Filters
ROR1 positive
Non Small Cell Lung Cancer
ROR1 positive
Non Small Cell Lung Cancer
LYL797
Sensitive: D – Preclinical
LYL797
Sensitive
:
D
LYL797
Sensitive: D – Preclinical
LYL797
Sensitive
:
D
ROR1 positive
Solid Tumor
ROR1 positive
Solid Tumor
LYL797
Sensitive: D – Preclinical
LYL797
Sensitive
:
D
LYL797
Sensitive: D – Preclinical
LYL797
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login